Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Melo

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Blood|October 1, 1996
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotypeJ V Melo
Leukemia|May 1, 1996
The molecular biology of chronic myeloid leukaemiaJ V Melo
Bailliere'S Clinical Haematology|June 1, 1997
BCR-ABL gene variantsJ V Melo
Cancer Letters|September 5, 2006
Resistance to imatinib mesylate in chronic myeloid leukaemiaJunia V Melo, Charles Chuah
Clinical Hematology International|March 20, 2023
Another Year to Celebrate Advances in Clinical HematologyMohamad Mohty, Junia V Melo
Oncotargets and Therapy|July 10, 2010
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinibCharles Chuah, Junia V Melo
International Journal of Hematology|July 9, 2004
Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant diseaseChikashi Yoshida, Junia V Melo
Clinical Hematology International|October 1, 2021
One Year into the COVID-19 PandemicMohamad Mohty, Junia V Melo
Clinical Hematology International|February 6, 2025
How to perform a high-quality peer reviewMohamad Mohty, Junia V Melo
Blood|August 2, 2002
Acquired resistance to imatinib mesylate: selection for pre-existing mutant cellsLucio Luzzatto, Junia V Melo
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Blood|October 1, 1996
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotypeJ V Melo
Leukemia|May 1, 1996
The molecular biology of chronic myeloid leukaemiaJ V Melo
Bailliere'S Clinical Haematology|June 1, 1997
BCR-ABL gene variantsJ V Melo
Cancer Letters|September 5, 2006
Resistance to imatinib mesylate in chronic myeloid leukaemiaJunia V Melo, Charles Chuah
Clinical Hematology International|March 20, 2023
Another Year to Celebrate Advances in Clinical HematologyMohamad Mohty, Junia V Melo
Oncotargets and Therapy|July 10, 2010
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinibCharles Chuah, Junia V Melo
International Journal of Hematology|July 9, 2004
Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant diseaseChikashi Yoshida, Junia V Melo
Clinical Hematology International|October 1, 2021
One Year into the COVID-19 PandemicMohamad Mohty, Junia V Melo
Clinical Hematology International|February 6, 2025
How to perform a high-quality peer reviewMohamad Mohty, Junia V Melo
Blood|August 2, 2002
Acquired resistance to imatinib mesylate: selection for pre-existing mutant cellsLucio Luzzatto, Junia V Melo
Pageof 33